Published in J Biol Chem on December 19, 2000
Efflux-mediated antifungal drug resistance. Clin Microbiol Rev (2009) 2.44
Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2. Cancer Res (2008) 2.04
A synonymous polymorphism in a common MDR1 (ABCB1) haplotype shapes protein function. Biochim Biophys Acta (2009) 1.79
Structure and function of efflux pumps that confer resistance to drugs. Biochem J (2003) 1.66
Structure and function of ABC transporters: the ATP switch provides flexible control. Pflugers Arch (2006) 1.54
Predicted mechanisms of resistance to mTOR inhibitors. Br J Cancer (2006) 1.17
The mechanism of action of multidrug-resistance-linked P-glycoprotein. J Bioenerg Biomembr (2001) 1.13
Inhibiting the function of ABCB1 and ABCG2 by the EGFR tyrosine kinase inhibitor AG1478. Biochem Pharmacol (2008) 1.12
Use of baculovirus BacMam vectors for expression of ABC drug transporters in mammalian cells. Drug Metab Dispos (2011) 1.05
Modulatory effects of plant phenols on human multidrug-resistance proteins 1, 4 and 5 (ABCC1, 4 and 5). FEBS J (2005) 1.04
The Arabidopsis peroxisomal ABC transporter, comatose, complements the Saccharomyces cerevisiae pxa1 pxa2Delta mutant for metabolism of long-chain fatty acids and exhibits fatty acyl-CoA-stimulated ATPase activity. J Biol Chem (2010) 0.96
Detailed characterization of cysteine-less P-glycoprotein reveals subtle pharmacological differences in function from wild-type protein. Br J Pharmacol (2001) 0.95
Modulation of the ATPase and transport activities of broad-acting multidrug resistance factor ABCC10 (MRP7). Cancer Res (2012) 0.95
ZD6474 reverses multidrug resistance by directly inhibiting the function of P-glycoprotein. Br J Cancer (2007) 0.94
Multiple transport-active binding sites are available for a single substrate on human P-glycoprotein (ABCB1). PLoS One (2013) 0.87
Interactions of mefloquine with ABC proteins, MRP1 (ABCC1) and MRP4 (ABCC4) that are present in human red cell membranes. Biochem Pharmacol (2005) 0.86
Mutations in intracellular loops 1 and 3 lead to misfolding of human P-glycoprotein (ABCB1) that can be rescued by cyclosporine A, which reduces its association with chaperone Hsp70. J Biol Chem (2013) 0.85
Inhibition of multidrug resistance-linked P-glycoprotein (ABCB1) function by 5'-fluorosulfonylbenzoyl 5'-adenosine: evidence for an ATP analogue that interacts with both drug-substrate-and nucleotide-binding sites. Biochemistry (2011) 0.83
Cryo-EM Analysis of the Conformational Landscape of Human P-glycoprotein (ABCB1) During its Catalytic Cycle. Mol Pharmacol (2016) 0.82
Drug-protein hydrogen bonds govern the inhibition of the ATP hydrolysis of the multidrug transporter P-glycoprotein. Biochem Pharmacol (2015) 0.81
The FLT3 inhibitor quizartinib inhibits ABCG2 at pharmacologically relevant concentrations, with implications for both chemosensitization and adverse drug interactions. PLoS One (2013) 0.80
Reaction dynamics of ATP hydrolysis catalyzed by P-glycoprotein. Biochemistry (2014) 0.79
Wallichinine reverses ABCB1-mediated cancer multidrug resistance. Am J Transl Res (2016) 0.79
Conserved Walker A cysteines 431 and 1074 in human P-glycoprotein are accessible to thiol-specific agents in the apo and ADP-vanadate trapped conformations. Biochemistry (2013) 0.78
Energy transduction and alternating access of the mammalian ABC transporter P-glycoprotein. Nature (2017) 0.78
Cooperativity between verapamil and ATP bound to the efflux transporter P-glycoprotein. Biochem Pharmacol (2016) 0.75
Global alteration of the drug-binding pocket of human P-glycoprotein (ABCB1) by substitution of fifteen conserved residues reveals a negative correlation between substrate size and transport efficiency. Biochem Pharmacol (2017) 0.75
Reconstitution of functional water channels in liposomes containing purified red cell CHIP28 protein. Biochemistry (1992) 3.84
HIV-1 protease inhibitors are substrates for the MDR1 multidrug transporter. Biochemistry (1998) 2.87
Overview: ABC transporters and human disease. J Bioenerg Biomembr (2001) 2.60
P-glycoprotein and multidrug resistance. Curr Opin Genet Dev (1996) 2.33
Evidence for two nonidentical drug-interaction sites in the human P-glycoprotein. Proc Natl Acad Sci U S A (1997) 2.10
Human P-glycoprotein exhibits reduced affinity for substrates during a catalytic transition state. Biochemistry (1998) 1.75
Reconstitution of sugar phosphate transport systems of Escherichia coli. J Biol Chem (1986) 1.69
Evidence for a requirement for ATP hydrolysis at two distinct steps during a single turnover of the catalytic cycle of human P-glycoprotein. Proc Natl Acad Sci U S A (2000) 1.58
Identification, purification, and reconstitution of OxlT, the oxalate: formate antiport protein of Oxalobacter formigenes. J Biol Chem (1992) 1.56
Bacterial anion exchange. Use of osmolytes during solubilization and reconstitution of phosphate-linked antiport from Streptococcus lactis. J Biol Chem (1986) 1.55
Imatinib mesylate and nilotinib (AMN107) exhibit high-affinity interaction with ABCG2 on primitive hematopoietic stem cells. Leukemia (2007) 1.52
Anion-exchange mechanisms in bacteria. Microbiol Rev (1990) 1.47
Calcium efflux from Escherichia coli. Evidence for two systems. J Biol Chem (1984) 1.47
Reconstitution of a bacterial periplasmic permease in proteoliposomes and demonstration of ATP hydrolysis concomitant with transport. Proc Natl Acad Sci U S A (1989) 1.46
Ultrastructure, pharmacologic inhibition, and transport selectivity of aquaporin channel-forming integral protein in proteoliposomes. Biochemistry (1994) 1.44
Characterization of phosphorylation-defective mutants of human P-glycoprotein expressed in mammalian cells. J Biol Chem (1996) 1.43
Improving cancer chemotherapy with modulators of ABC drug transporters. Curr Drug Targets (2011) 1.35
Biochemical mechanism of modulation of human P-glycoprotein (ABCB1) by curcumin I, II, and III purified from Turmeric powder. Biochem Pharmacol (2004) 1.29
Single-step doxorubicin-selected cancer cells overexpress the ABCG2 drug transporter through epigenetic changes. Br J Cancer (2008) 1.27
Variable stoichiometry of phosphate-linked anion exchange in Streptococcus lactis: implications for the mechanism of sugar phosphate transport by bacteria. Proc Natl Acad Sci U S A (1986) 1.22
Phosphate/hexose 6-phosphate antiport in Streptococcus lactis. J Bacteriol (1984) 1.21
Characterization of phosphate:hexose 6-phosphate antiport in membrane vesicles of Streptococcus lactis. J Biol Chem (1984) 1.17
Characterization of the catalytic cycle of ATP hydrolysis by human P-glycoprotein. The two ATP hydrolysis events in a single catalytic cycle are kinetically similar but affect different functional outcomes. J Biol Chem (2001) 1.13
The mechanism of action of multidrug-resistance-linked P-glycoprotein. J Bioenerg Biomembr (2001) 1.13
Evidence for the interaction of imatinib at the transport-substrate site(s) of the multidrug-resistance-linked ABC drug transporters ABCB1 (P-glycoprotein) and ABCG2. Leukemia (2007) 1.12
Functional characterization of a glycine 185-to-valine substitution in human P-glycoprotein by using a vaccinia-based transient expression system. Mol Biol Cell (1996) 1.11
The mechanism of glucose 6-phosphate transport by Escherichia coli. J Biol Chem (1988) 1.09
Functional characterization of glycosylation-deficient human P-glycoprotein using a vaccinia virus expression system. J Membr Biol (2000) 1.09
Reconstitution of ATP-dependent calcium transport from streptococci. J Biol Chem (1986) 1.08
Photoaffinity labeling of human P-glycoprotein: effect of modulator interaction and ATP hydrolysis on substrate binding. Methods Enzymol (1998) 1.04
Heterologous expression systems for P-glycoprotein: E. coli, yeast, and baculovirus. J Bioenerg Biomembr (1995) 1.04
Mechanism of action of human P-glycoprotein ATPase activity. Photochemical cleavage during a catalytic transition state using orthovanadate reveals cross-talk between the two ATP sites. J Biol Chem (1998) 1.02
Structural flexibility of the linker region of human P-glycoprotein permits ATP hydrolysis and drug transport. Biochemistry (1998) 1.01
Rate-limiting step in electron transport. Osmotically sensitive diffusion of quinones through voids in the bilayer. J Biol Chem (1993) 0.96
Reconstitution of the lysosomal proton pump. Proc Natl Acad Sci U S A (1987) 0.95
Contribution to substrate specificity and transport of nonconserved residues in transmembrane domain 12 of human P-glycoprotein. Biochemistry (1998) 0.95
Functional reconstitution of prokaryote and eukaryote membrane proteins. Arch Biochem Biophys (1989) 0.93
Effects of phosphorylation of P-glycoprotein on multidrug resistance. J Bioenerg Biomembr (1995) 0.86
Functionally similar vanadate-induced 8-azidoadenosine 5'-[alpha-(32)P]Diphosphate-trapped transition state intermediates of human P-glycoprotin are generated in the absence and presence of ATP hydrolysis. J Biol Chem (2001) 0.84
Synthesis and preliminary analysis of a P-glycoprotein-specific [3H]-benzophenone photoaffinity label based on (-)-stipiamide. Bioorg Med Chem Lett (2000) 0.83
Analysis of F9 point mutations and their correlation to severity of haemophilia B disease. Haemophilia (2012) 0.82
Anion exchange in bacteria: reconstitution of phosphate: hexose 6-phosphate antiport from Streptococcus lactis. Methods Enzymol (1986) 0.81
Calcium, sodium, phosphate and arsenate transport in cells and vesicles of Escherichia coli. Prog Clin Biol Res (1984) 0.81
Ion extrusion systems in bacteria. Ann N Y Acad Sci (1985) 0.79
Bacterial expression of the linker region of human MDR1 P-glycoprotein and mutational analysis of phosphorylation sites. Biochemistry (1995) 0.79
Osmotic perturbations induce differential movements in the core and periphery of proteins, membranes and micelles. Biophys Chem (2001) 0.78
Evidence for the vectorial nature of drug (substrate)-stimulated ATP hydrolysis by human P-glycoprotein. J Biol Chem (2001) 0.78
Volume regulation of spermatozoa by quinine-sensitive channels. Mol Reprod Dev (1997) 0.78
Anion exchange in bacteria. Variable stoichiometry of phosphate: sugar 6-phosphate antiport. Ann N Y Acad Sci (1985) 0.78
The synthesis and evaluation of a solution phase indexed combinatorial library of non-natural polyenes for reversal of P-glycoprotein mediated multidrug resistance. J Org Chem (2000) 0.77
Genetic determinants of immunogenicity to factor IX during the treatment of haemophilia B. Haemophilia (2014) 0.77
What does a common channel for electrolytes and non-electrolytes in the sperm mean? J Theor Biol (2000) 0.77
Solvent interconnectedness permits measurement of proximal as well as distant phase transitions in polymer mixtures by fluorescence. Biophys Chem (2001) 0.77
Exploiting multidrug resistance to treat cancer. Cold Spring Harb Symp Quant Biol (1994) 0.77
Observations regarding the immunogenicity of BDD-rFVIII derived from a mechanistic personalized medicine perspective. J Thromb Haemost (2012) 0.75
Phospholipid metabolism in E. coli during growth in high glucose medium. Indian J Biochem Biophys (1980) 0.75
Reconstitution of a passive Ca(2+)-transport pathway from the basolateral plasma membrane of rat parotid gland acinar cells. J Membr Biol (1995) 0.75
Reconstitution of phosphate-linked antiport from Streptococcus lactis. Biochem Biophys Res Commun (1985) 0.75